Presentation Information
[16p-W2_402-9]Ultrasensitive Single-Molecule Quantum Detection of O6-Methylguanine for Brain Tumor Diagnostics
〇Shinya Sakano1, Takahito Ohshiro2, Yuki Komoto2, Masateru Taniguchi2 (1.Susumu CO., LTD., 2.Sanken, Osaka Univ.)
Keywords:
single-molecule detection,Tunnel-Current,Biopolymer
DNA and other nucleic acids undergo various chemical lesions through alkylation and oxidation, contributing to cell death and genomic instability. Among these, O6-methylguanine (O6-MeG), induced by the brain tumor drug temozolomide (TMZ), is a key determinant of drug sensitivity, together with its repair by MGMT (O6-methylguanine-DNA methyltransferase). However, because such lesions occur at extremely low frequency and coexist with oxidative damage (e.g., 8-oxoG), conventional ensemble measurements cannot directly quantify O6-MeG. Here, we present a single-molecule quantum sensing approach using nanogap electrodes to discriminate O6-MeG, 8-oxoG, and normal nucleic acids based on their electrical fingerprints and dynamic behavior. This technique, previously applied to nucleic acids and amino acids, enables high-precision analysis of damaged nucleic acids, offering new insights for brain tumor diagnostics and drug response evaluation.
